None listed
Conditions
Interventions
Test foods high-dose, single ingestion. Wash out. Test foods low-dose, single ingestion. Wash out. Control foods, single ingestion.
Test foods low-dose, single ingestion. Wash out. Control foods, sing
Sponsors
KSO Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Healthy Japanese males and females aged 20 to 64 years-old. 2) Subjects who have no habit of smoking. 3) Subjects who do not habitually consume a large amounts of alcohol. 4) Subjects whose BMI are less than 30. 5) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: Subjects(who) 1) contract or have a history of serious diseases (eg, liver, kidney, digestive, heart, respiratory, endocrine, metabolic, skeletal muscle and/or tendon disease) 2) have a chronic disease and regularly use medications. 3) contract or have a surgical history of digestive disease affecting digestion and absorption. 4) have declared allergic reaction to ingredients contained in test foods or loading foods. 5) can't stop using supplements, and/or functional foods (including Food for Specified Health Uses, Foods with Function Claims, or enriched foods or nutritional supplements which contain proteins and/or amino acids). 6) were judged as unsuitable for the current study by screening tests. 7) are diagnosed as anemic by the screening tests and unsuitable for frequent blood sampling. 8) have had diarrhea within the last 1 week prior to the screening tests. 9) can't stop drinking from 2 days before each measurement. 10) pregnant or breastfeed or planning to become pregnant during this study. 11) have a habit of skipping breakfast. 12) have excessive alcohol intake more than 20 g/day of pure alcohol equivalent for more than 4 days a week. 13) are shiftworker and/or midnight-shift worker. 14) are under treatment for or have a history of drug addiction and/or alcoholism. 15) have donated over 200 mL of blood and/or blood components within the last 1 month or over 400 mL of blood and/or blood components within the last 3 months prior to the current study. 16) are participating in or willing to participate in other clinical studies. 17) are judged as unsuitable for the current study by the investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Appetite (hunger, fullness, prospective consumption, satiety) score on the Japanese version of appetite sensations questionnaire using visual analogue scales (VAS) after the single ingestion. | — |
Secondary
| Measure | Time frame |
|---|---|
| The blood concentration of on appetite related hormones after the single ingestion. | — |
Countries
Japan
Contacts
Public ContactYoshika Komori
KSO Corporation Clinical Trial Management department
Outcome results
None listed